Results 81 to 90 of about 206,766 (202)

Repeated-dose toxicity and immunogenicity evaluation of a recombinant subunit COVID-19 vaccine (ZF2001) in rats

Frontiers in Cellular and Infection Microbiology
Coronavirus disease 19 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), had given rise to a massive epidemic. Owing to the high morbidity and mortality of COVID-19 and the lack of effective therapies, safe and effective
Ruimin Sun, Ruimin Sun, Lijuan Xia, Lijuan Xia, Guangbiao She, Guangbiao She, Jinrong Li, Yiru Wang, Yiru Wang, Yunxiang Chen, Yunxiang Chen, Qian Yang, Siming Zhang, Fang Liu, Ying Chen, Liyan Zhang, Chengda Zhang, Wanqiang Lv, Wanqiang Lv, Enqi Huang, Enqi Huang, Lijiang Zhang, Lijiang Zhang, Lijiang Zhang   +23 more
doaj   +1 more source

Evidence of blood stage efficacy with a virosomal malaria vaccine in a Phase IIa clinical trial

, 2008
Background Previous research indicates that a combination vaccine targeting different stages of the malaria life cycle is likely to provide the most effective malaria vaccine.
Zurbriggen, R, Gerd Pluschke, Sarah C. Gilbert, Hill, Adrian, Hutchings, Claire, Gilbert Sarah C., Sinden, Robert, Gilbert, Sarah, Pluschke, G, Gilbert, Sarah C., Zurbriggen Rinaldo, Vogel, Denise, Jack L. Williams, Correa, S, Andrews Laura, Okitsu, SL, Westerfeld Nicole, Andrews, Laura, Vogel, D, David W. Porter, Thompson, Fiona, Okitsu, Shinji, Ian Poulton, Todryk, S, Shinji L. Okitsu, Denise Vogel, Dunachie Susanna, Thompson Fiona M., Berthoud, Tamara, Andrews, L, Sinden, R, Porter David W., Pluschke, Gerd, Sarah C Gilbert, Sinden Robert, Poulton Ian, Fiona M Thompson, Berthoud, T, Zurbriggen, Rinaldo, Rinaldo Zurbriggen, Susanna Dunachie, Westerfeld, Nicole, Tamara Berthoud, Todryk, Stephen, Okitsu Shinji L., Hill Adrian V. S., Correa Simon, Berthoud Tamara, Dunachie, S, Westerfeld, N, David W Porter, Nicole Westerfeld, Todryk Stephen, Porter, David, Correa, Simon, Thompson, FM, Pluschke Gerd, Hutchings, C, Poulton, Ian, Hutchings Claire, Williams, JL, Vogel Denise, Shinji L Okitsu, Fiona M. Thompson, Poulton, I, Jack L Williams, Simon Correa, Laura Andrews, Dunachie, Susanna, Adrian V S Hill, Robert Sinden, Porter, DW, Stephen Todryk, Williams, Jack, Claire Hutchings, Williams Jack L.   +75 more
core   +2 more sources

Vaccine safety [PDF]

Paediatrics & Child Health, 2007
openaire   +2 more sources

Malaria immunology and vaccine development

, 2008
This thesis describes work undertaken by the author at the University of Oxford. Itbegins by providing an introduction to malaria infection and pathophysiology, anda review of the latest attempts to produce an effective malaria vaccine.
Thompson, Fiona Mary
core  

Identification of seizures among adults and children following influenza vaccination using health insurance claims data

, 2017
Introduction: Post-licensure surveillance of adverse events following vaccination or prescription drug use often relies on electronic healthcare data to efficiently detect and evaluate safety signals.
Thyagarajan, Veena;Su, Sue;Gee, Julianne;Duffy, Jonathan;McCarthy, Natalie L.;Chan, K. Arnold;Weintraub, Eric S.;Lin, Nancy D., 陳建煒   +1 more
core   +1 more source

Vaccine Safety

Pediatric Infectious Disease Journal, 2008
C.J. Clements, G. Lawrence
  +5 more sources

A Novel, Safe, Non-Adjuvanted Alphavirus Replicon-Based Vaccine Expressing the Feline Leukemia Virus Envelope Protein Protects Against Virulent FeLV Challenge

Vaccines
Background/Objectives: A number of different vaccines against feline leukemia virus (FeLV) are available; however, there is continuous debate regarding the efficacy advantages of adjuvanted vaccines versus the potential safety advantages of non ...
Kari Carritt, Randall Davis, Ken Stachura, Paige Crumley, Mark Mogler, Madeleine Stahl, Lijuan Deng, Zach Xu, Ian Tarpey   +8 more
doaj   +1 more source

The safety of co-administration of recombinant zoster vaccine (Shingrix) and influenza vaccines in the elderly in VAERS during 2018–2024

Human Vaccines & Immunotherapeutics
This post-marketing safety study evaluated the co-administration of recombinant zoster vaccine (RZV, Shingrix) and influenza vaccines (HD-IIV/aIIV/RIV) in adults aged ≥ 65 years using U.S. VAERS data (2018–2024).
Yihao Li, Huilin Xia, Hong Zhang, Yuan Lu, Hang Zhou, Rongbin Yu, Peng Huang   +6 more
doaj   +1 more source

Humoral Response and Safety after a Fourth Dose of the SARS-CoV-2 BNT162b2 Vaccine in Cancer Patients Undergoing Active Treatment—Results of a Prospective Observational Study

Only a few studies have been carried out on the efficacy and safety of a fourth dose of the COVID-19 vaccine in patients with cancer. In this prospective observational study, we aimed to assess the serological response and safety of the fourth booster ...
Camilla Di Nunzio, Luigi Cavanna, Chiara Citterio, Giuliana Lo Cascio, Claudia Biasini   +4 more
core   +1 more source

01-05 STATEMENT OF POLICY

, 2014
Policy Confidence in the safety of the vaccines used to protect the residents of our nation is critical to assuring that the vaccines are used as widely, effectively and appropriately as possible.
Vaccine Safety
core